Q3 2025 Holdings
Filed 2025-11-12 | 82 holdings | $741.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $45.8M | 539,704 | 6.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $37.4M | 369,996 | 5.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $36.8M | 844,633 | 5.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $32.2M | 372,300 | 4.3% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $31.5M | 1,577,283 | 4.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $30.6M | 643,636 | 4.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $29.8M | 206,648 | 4.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $26.6M | 674,966 | 3.6% |
| Uniqure NV(QURE) | SHS | N90064101 | $26.6M | 455,000 | 3.6% |
| CG Oncology Inc(CGON) | COM | 156944100 | $25.7M | 638,346 | 3.5% |
| United Therapeutics Corp delPut | PUT | 91307C952 | $25.1M | 59,900 | 3.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $23.4M | 1,948,808 | 3.2% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $21.2M | 220,902 | 2.9% |
| Fractyl Health Inc(GUTS) | COM | 35168W103 | $16.9M | 10,600,000 | 2.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $16.6M | 1,363,378 | 2.2% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $16.4M | 1,000,000 | 2.2% |
| Ultragenyx Pharmaceutical inCall | CALL | 90400D908 | $15.9M | 528,200 | 2.1% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $12.6M | 4,779,082 | 1.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $11.7M | 815,075 | 1.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $11.6M | 211,000 | 1.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $11.3M | 314,339 | 1.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $11.3M | 80,419 | 1.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $10.6M | 53,554 | 1.4% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $9.9M | 2,833,988 | 1.3% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $9.5M | 700,000 | 1.3% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $9.2M | 1,042,757 | 1.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $9.2M | 720,922 | 1.2% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $9.1M | 933,541 | 1.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $9.0M | 348,922 | 1.2% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $8.7M | 233,920 | 1.2% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $8.1M | 235,791 | 1.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.1M | 463,708 | 1.0% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $6.1M | 203,946 | 0.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $5.6M | 259,509 | 0.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $5.4M | 180,513 | 0.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $5.4M | 588,789 | 0.7% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $5.3M | 457,414 | 0.7% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $5.3M | 994,754 | 0.7% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $5.2M | 778,611 | 0.7% |
| Cogent Biosciences IncCall | CALL | 19240Q901 | $5.2M | 360,000 | 0.7% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $5.1M | 694,942 | 0.7% |
| Compugen LTD(CGEN) | ORD | M25722105 | $4.9M | 3,311,165 | 0.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $4.6M | 183,903 | 0.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $4.4M | 88,686 | 0.6% |
| Cerus Corp(CERS) | COM | 157085101 | $4.3M | 2,715,786 | 0.6% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $4.2M | 1,897,383 | 0.6% |
| Tela BIO Inc(TELA) | COM | 872381108 | $4.1M | 2,782,923 | 0.6% |
| Aardvark Therapeutics Inc(AARD) | COM | 002942100 | $4.1M | 306,912 | 0.6% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $4.0M | 250,606 | 0.5% |
| Benitec Biopharma Inc(BNTC) | COM NEW | 08205P209 | $3.9M | 276,267 | 0.5% |